The healthcare-acquired infection is a new infection that develops in a patient during hospitalization.
This report contains market size and forecasts of Healthcare-Acquired Infection in Global, including the following market information:
- Global Healthcare-Acquired Infection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Healthcare-Acquired Infection market was valued at 24880 million in 2021 and is projected to reach US$ 40490 million by 2028, at a CAGR of 7.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pharmaceutical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Healthcare-Acquired Infection include Pfizer, Novartis, Roche, Sanofi, Abbott, BD and Hologic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Healthcare-Acquired Infection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Healthcare-Acquired Infection Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Healthcare-Acquired Infection Market Segment Percentages, by Type, 2021 (%)
- Pharmaceutical Treatment
- Environment Treatment
- Medical Devices Management
Global Healthcare-Acquired Infection Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Healthcare-Acquired Infection Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinics
- Ambulatory Surgery Centers
- Others
Global Healthcare-Acquired Infection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Healthcare-Acquired Infection Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Healthcare-Acquired Infection revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Healthcare-Acquired Infection revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Novartis
- Roche
- Sanofi
- Abbott
- BD
- Hologic
